CCSE Pilot for Lenacapavir 2026 – Up to US$200,000 for Sub-Saharan Africa Apply Now
Join Our WhatsApp Channel for Latest UpdatesCCSE Pilot for Lenacapavir 2026 – Up to US$200,000 for Sub-Saharan Africa | Apply Now
Community and Civil Society Engagement (CCSE) Pilot for Lenacapavir – Up to US$200,000 – Sub-Saharan Africa
Complete guide to eligibility, focus areas, funding, and application process
Quick Highlights
| Parameter | Details |
|---|---|
| Opportunity | CCSE Pilot for Lenacapavir |
| Funding | Up to US$200,000 |
| Focus | Equitable access to long-acting HIV prevention |
| Eligibility | CBOs, CSOs, networks & coalitions in Sub-Saharan Africa |
| Application | Expression of Interest (EOI) |
| Deadline | 28 August 2026 (23:59 SAST) |
| Official Website |
Opportunity Overview
| Field | Details |
|---|---|
| Host Organisation | CCSE Pilot / Wits RHI |
| Opportunity Category | Grant Funding |
| Location | Sub-Saharan Africa |
| Application Mode | Online |
| Official Language | English |
About the CCSE Pilot for Lenacapavir
Applications are now open for the Community and Civil Society Engagement (CCSE) Pilot for Lenacapavir, an initiative supporting community-led action to promote equitable access to long-acting HIV prevention. The funding opportunity is aimed at community-based organisations (CBOs), civil society organisations (CSOs), networks and coalitions working in Sub-Saharan Africa.
Successful applicants may receive funding of up to US$200,000 to support activities that strengthen community and civil society engagement around access to lenacapavir as a long-acting HIV prevention option.
Why You Should Apply
| Benefit | Description |
|---|---|
| Substantial Funding | Up to US$200,000 |
| Community Impact | Support equitable HIV prevention access |
| Regional Focus | Sub-Saharan Africa |
| Community-Led | Support community-led action |
| Health Equity | Contribute to health equity |
| Flexible Application | Expression of Interest process |
What is the CCSE Pilot?
The Community and Civil Society Engagement Pilot is designed to support community-led approaches that can contribute to equitable access to lenacapavir for HIV prevention. Lenacapavir is a long-acting HIV prevention option, and the initiative recognises the role that communities and civil society organisations can play in ensuring that new prevention technologies reach people who need them.
Through the pilot, participating organisations can contribute to community engagement, advocacy and other activities intended to support more equitable access.
Eligibility Criteria
| Criteria | Details |
|---|---|
| Organization Type | CBOs, CSOs, civil society networks, coalitions |
| Location | Sub-Saharan Africa |
| Focus | HIV prevention, community health, health equity |
| Community Engagement | Work directly with communities affected by HIV |
Funding
| Parameter | Details |
|---|---|
| Maximum Amount | Up to US$200,000 |
| Purpose | Community-led action for equitable access to lenacapavir |
| Activities | Community engagement, advocacy, and related activities |
Focus Areas
| Area | Description |
|---|---|
| HIV Prevention | Long-acting HIV prevention |
| Community Health | Health equity and access |
| Health Technologies | Access to new prevention technologies |
| Community Advocacy | Community-led advocacy |
| Public Health | HIV-related policy and advocacy |
| Sexual & Reproductive Health | SRH and HIV |
| Marginalized Communities | Underserved populations |
Why Community-Led Action Matters
The introduction of new health technologies does not automatically guarantee equitable access. Community and civil society organisations can play an important role in identifying barriers, amplifying community priorities, supporting informed engagement and advocating for approaches that respond to the needs of affected populations.
The CCSE Pilot seeks to strengthen this role by supporting organisations that can contribute community perspectives and locally relevant action around HIV prevention.
Application Process
| Step | Action |
|---|---|
| 1 | Review the official call documentation |
| 2 | Confirm eligibility criteria |
| 3 | Prepare your Expression of Interest |
| 4 | Demonstrate experience and community engagement capacity |
| 5 | Submit EOI before the deadline |
Important Dates
| Event | Date |
|---|---|
| EOI Deadline | 28 August 2026 (23:59 SAST) |
Important Links
| Description | URL |
|---|---|
| Apply Online | https://wrhi.ac.za/community-and-civil-society-engagement-ccse-pilot-for-lenacapavir/ |
| Official Website |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Q1. What is the CCSE Pilot? | Funding for community-led HIV prevention action in Sub-Saharan Africa. |
| Q2. How much funding is available? | Up to US$200,000. |
| Q3. Who can apply? | CBOs, CSOs, networks & coalitions in Sub-Saharan Africa. |
| Q4. What is the focus? | Equitable access to lenacapavir (long-acting HIV prevention). |
| Q5. What is the application process? | Expression of Interest (EOI). |
| Q6. What is the deadline? | 28 August 2026 (23:59 SAST). |
| Q7. Where is it focused? | Sub-Saharan Africa. |
| Q8. How to apply? | Through the official Wits RHI website. |
CareerFlora Expert Insight
The CCSE Pilot for Lenacapavir offers a significant funding opportunity for community-based and civil society organisations in Sub-Saharan Africa. With up to US$200,000 available, this initiative supports community-led action to promote equitable access to long-acting HIV prevention.
For organisations working on HIV prevention, community health, and health equity, this grant provides resources to strengthen community engagement and advocacy around new prevention technologies.
Best Opportunity For
| Category | Suitable |
|---|---|
| Community-Based Organisations | Yes |
| Civil Society Organisations | Yes |
| Networks & Coalitions | Yes |
| HIV Prevention Organisations | Yes |
| Health Equity Organisations | Yes |
| Sub-Saharan Africa Organisations | Yes |
Competition Level
| Category | Level |
|---|---|
| Overall Competition | High |
| Selection Difficulty | Competitive |
| Application Complexity | Medium |
CareerFlora Recommendation
| Area | Details |
|---|---|
| Funding Opportunity | Excellent |
| Impact Potential | Very High |
| Application Difficulty | Medium |
| Apply Early | Strongly Recommended |
Final Call-to-Action
Apply for CCSE Pilot for Lenacapavir 2026 before 28 August 2026.
Visit the official Wits RHI website: https://wrhi.ac.za/community-and-civil-society-engagement-ccse-pilot-for-lenacapavir/
Review the official call documentation carefully.
Confirm your organisation's eligibility.
Prepare your Expression of Interest.
Submit before the deadline.
Follow CareerFlora for the latest updates.
